Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
140 Cards in this Set
- Front
- Back
what percent of the body water is intracellular, extracellular and in plasma?
|
intracellular - 2/3
extracellular - 1/3 plasma - 5% |
|
what controls movement of water and salts generally?
|
opposing effects of hydrostatic pressure out & colloid osmotic pressure in
|
|
where does any residual fluid left at the end of inflow at the venular end of the microcirculation go?
|
lymphatics
|
|
what conditions lead to increased interstitial fluid?
|
increased capillary pressure
decreased colloid osmotic pressure |
|
what are the main causes of increased hydrostatic pressure & give at least 2 examples of each?
|
impaired venous return
eg CCF, constrictive pericarditis, ascites, venous obstruction/compression (thrombosis, mass) arteriolar dilatation eg heat, neurohumeral dysregulation |
|
what are the 5 pathophysiologic categories of oedema?
|
increased hydrostatic pressure
reduced plasma osmotic pressure lymphatic obstruction sodium retention inflammation |
|
what are the 4 casuses of reduced plasma osmotic pressure?
|
nephrotic syndrome (protein losing nephropathies)
ascites (liver cirrhosis) malnutrition protein losing gastroenteropathy |
|
what are the 4 causes of lymphatic obstruction?
|
inflammatory
neoplastic postsurgical post irradiation |
|
what are the 2 causes of sodium retention?
|
excessive oral intake + renal insufficiency
increased tubular reabsorption of sodium (renal hypoperfusion or increased renin-angiotensin-aldosterone secretion) |
|
what are the 3 inflammatory causes of oedema
|
acute inflam
chronic inflam angiogenesis |
|
what is anasarca?
|
severe & generalised oedema w widespread subcutaneous tissue swelling
|
|
what distinguishes oedema from hydrothorax/ hydropericardium/ hydroperitoneum (ascites)?
|
oedema is an abnormal increase in interstitial fluid
others are collections in body cavities |
|
what is the difference between transudate & exudate?
|
transudate - protein poor oedema caused by increased hydrostatic pressure/decreased colloid pull
exudate - protein rich, caused by inflammation that leads to increased vascular permeability |
|
does Na/water retention cause increased hydrostatic pressure or decreased colloid pressure?
|
both - intravascular volume expansion causes increased hydrostatic pressure & dilution causes decreased colloid pressure
|
|
draw the pathway leading to oedema from heart failure, liver failure & the decreased protein/protein loss causes?
|
robbins fig 4-2
|
|
how does activation of the renin/angiotensin system lead to oedema?
|
retains sodium & water -> increased blood volume
|
|
what kind of oedema is SIADH associated with?
|
cerebral
not peripheral |
|
what parasite can cause oedema & how?
|
filiaris
can cause lymphatic fibrosis of inguinal region -> massive oedema of external genitalia & lower limbs (elephantiasis) |
|
in what settings can pulmonary oedema be seen?
|
LVF
renal failure ARDS pulmonary inflammation/infection |
|
when can oedema be immediately life threatening?
|
if cerebral - can cone
|
|
what is hyperaemia?
|
active process where arteriolar dilatation leads to increased blood flow (eg inflammation, exercising skeletal muscle)
|
|
what is congestion?
|
passive process resulting from reduced outflow of blood from a tissue (systemic eg cardiac failure or local eg isolated venous obstruction)
|
|
how does hyperaemic tissue look different to congested tissue?
|
hyperaemic - red because tissues congested w oxygenated blood
congested - dusky due to red cell stasis & accumulation of deoxygenated haemoglobin |
|
what consequences does chronic passive congestion have?
|
hypoxia w potential ischaemic tissue injury & scarring
can have capillary rupture w small haemorrhagic foci & haemosiderin staining of skin w subsequent catabolism of extravasated red cells |
|
what is the definition of haemorrhage?
|
extravasation of blood into the extravascular space
|
|
what is the containment of haemorrhage in a tissue called?
|
haematoma
|
|
what are petechiae usually caused by? (3)
|
locally increased intravascular pressure
thrombocytopaenia defective platelet fn eg uraemia |
|
what distinguishes petechiae, purpura & eccymoses?
|
petechia are minute, purpura >3mm; ecchymoses (bruises) are >1-2cm
|
|
what causes purpura?
|
same causes as petechia plus vasculitis, trauma or increased vascular fragility (eg amyloidosis)
|
|
what compounds characterise colour changes in a bruise?
|
haemoglobin (red blue)
-> bilirubin (blue green) -> haemosiderin (gold brown) |
|
what percent of blood loss can be tolerated without haemodynamic instability by healthy adults?
|
20% rapid
larger slowly depending on site |
|
what is pathologic counterpart of haemostasis?
|
thrombosis
|
|
what are the 3 components of haemostasis & thrombosis?
|
vascular endothelium
platelets coagulation cascade |
|
what is the normal sequence of events at a site of vascular injury?
|
arteriolar vasoconstriction (transient)
primary haemostasis - formation of platelet plug secondary haemostasis consolidates initial platelet plug with fibrin meshwork & recruitment of extra platelets thrombus formation (polymerised fibrin & platelet aggregates) |
|
what happens in secondary haemostasis?
|
tissue factor exposed -> combines w factor VII to initialte coag cascade-> thrombin generation -> thrombin cleaves circulating fibrinogen -> fibrin meshwork
|
|
what happens in primary haemostasis?
|
subendothelial extracellular matrix exposed (highly thrombogenic) -> platelets adhere -> platelets change from round to flat -> granules released -> more platelets recruited -> haemostatic plug aggregates
|
|
how important is endothelium on regulation of homeostasis?
|
key - balance of anti and prothrombotic activities of endothelium determines whether thrombus forms, propagates or dissolves
|
|
what is the normal state of endothelium & how can it become procoagulable?
|
usually anti platelent, anticoagulant & fibrinolytic but becomes pro coagulant after injury/activation?
|
|
what apart from trauma can activate endothelium to become prothrombotic? (4)
|
infectious agents
haemodynamic forces plasma mediators cytokines |
|
what are the normal antiplatelet effects of the endothelium?
|
non activated platelets don't adhere to endothelium
endothelium normally produces prostacyclin & NO which impede platelet adhesion |
|
what are the fibrinolytic effects of normal endothelium?
|
rPA synthesised by endothelium cleaves plasminogen -> plasmin which in turn cleaves fibrin -> degrades thrombin
|
|
what are the anticoagulant effects of normal endothelium?
|
heparin like molecules inactivate thrombin, factors Xa & IXa
|
|
what platelet effects result from endothelial injury?
|
platelets contact underlying ECM & then subsequent platelet adhesion occurs via von willebrand's factor normally produced by endothlium
|
|
what are the procoagulant effects seen in endothelial injury?
|
tissue factor synthesised in response to cytokines (eg TNF, IL1) or bacterial endotoxins -> activates extrinsic clotting cascade
activated endothelium augments factors IXa & Xa |
|
what are the antifibrinolytic effects seen in endothelial injury?
|
inhibitors of plasminogen activators
|
|
summarise the role of endothelium in haemostasis?
|
intact endothelium is inhibitory to platelet formation & clotting but injured or activated endothelial becomes procoagulant
|
|
what is the role of platelets in haemostasis? (2)
|
1. haemostatic plug that seals vascular defects
2. surface to recruit/concentrate activated coag factors |
|
what are the 3 stages of platelet activity after encountering ECM constitutents like collagen & von willebrand's factor?
|
adhesion & flattening
secretion (release reaction) aggregation |
|
what kind of platelet secretion is especially important & why?
|
releasing contents of dense bodies
- Ca++ important in coag cascade - ADP potent activator of platelet aggregation |
|
what does thromboxane A2 do?
|
platelet derived stimulus that amplifies platelet aggregation
|
|
summarise the stages of platelet aggregation?
|
initially is reversible but then thrombin generated by coag cascade leads to platelet contraction & an irreversibly fused haemostatic plug
|
|
what are the 2 mechanisms by which thrombin stabilises the platelet plug?
|
1. binds to platelet membrane -> induces further aggregation -> platelet contraction -> irreversible secondary haemostatic plug
2. converts fibrinogen to fibrin, cementing the platelets in place |
|
what does ADP activation of platelets achieve?
|
conformational change in GpIIb-IIIa receptor -> binding to fibrinogen
|
|
how does clopidogrel affect platelets?
|
binds to ADP
|
|
how does aspirin affect platelets?
|
irreversible COX inhibitor
permanent blocks platelet derived prostaglandin TxA2 (which activates platelet aggregation & is a vasoconstrictor) nb aspirin also inhibits endothelial prostaglandin PGI2 but endothelium can resynthesise active COX & overcome blockade |
|
what is the most important coagulation factor?
|
thrombin
|
|
what are the components of the complex at each step of the coag cascade? (3)
|
enzyme
substrate cofactor (reaction accelerator) |
|
where are the compoenets of the coag cascade assemebled & what holds them together?
|
assembled on phospholipid surface
held together by Ca++ ions |
|
what coag factors require vitamin K?
|
II, XII, IX, X
|
|
where do the intrinsic & extrinsic pathways converge?
|
activation of factor X
|
|
what is the difference between intrinsic & extrinsic pathways?
|
an artefact of in vitro testing - the extrinsic pathway required an exogenous trigger but intrinsic only needed exposing factor XII to a surface.
in the body there are several connections between the 2 pathways |
|
which pathway is most physiologically relevant for coagulation in the setting of vascular injury?
|
extrinsic - activated by tissue factor (factor III) expressed at sites of injury
|
|
what does prothrombin time asses? what about partial thromboplastin time?
|
prothrombin - extrinsic pathway (VII, X, II, V)
APPT - intrinsic |
|
what restricts coagulation cascade to the site of the injury to prevent runaway clotting of the whole vascular tree?
|
anthithrombins
protein C & S TFPI |
|
how does heparin mimic anticoagulation cascade?
|
antithrombin III activated by binding to heparin like molecules on endothelium
|
|
what limits the size of a thrombus? what is the primary mediator of this?
|
fibrinolysis
largely mediated through the enzyme plasmin which breaks down fibrin & interferes w its polymerisation |
|
what is tPA? where is it normally made & why is it usefully therapeutically?
|
tissue plaminogen activator - synthesised by endothelium & most active when bound to fibrin - useful therapeutically as confines fibrinolytic activity to sites of recent thrombus
|
|
what is virchow's triad?
|
endothelial injury
stasis/turbulent blood flow hypercoagulability of blood |
|
what does virchow's triad signify?
|
three primary abnormalities that lead to thrombus formation
|
|
where is endothelial injury particularly important?
|
thrombus formation in the heart/arterial circulation (normally high flow rates might otherwise impede clotting by platelet flow speed & wash out of coagulants)
|
|
what kind of endothelial damage needs to occur for thrombus to form?
|
doesn't need to be physically disrupted for a clot to occur - just need to disturb the balance of coagulants/anticoagulants ie dysfunctional cells can clot with intact endothelium
|
|
what is laminar blood flow?
|
blood cellular components flow centrally, separated from endothelium by slower moving plasma
|
|
what are the 3 mechanisms by which stasis/turbulence leads to clotting?
|
- promotes endothelial activation via flow induced changes in endothelial gene expression
- disrupts laminar flow, bringing platelets into contact w endothelium - prevents washout of activated clotting factors & inflow of clotting factor inhibitors |
|
when is turbulence/stasis clinically relevant? (6)
|
stasis in aneurysms/dilatations
turbulence in ulcerated atherosclerotic plaques non contractile myocardium in MI rheumatic mitral valve stenosis -> L atrial dilatation -> increased clotting risk (esp w AF) hyperviscosity (eg polycythemia vera) -> small vessel stasis sickle cells -> obstructions |
|
what is hypercoagulability?
|
any alteration of coag pathways which predisposes to thrombosis
primary (genetic) vs secondary (acquired) |
|
what percent of caucasians have factor V leiden?
|
2-15%
|
|
what is factor V leiden?
|
a mutation that makes factor V resistant to cleavage by protein C
|
|
what is the second most common hypercoagulable mutation?
|
prothrombin mutation -> elevated prothrombin levels
|
|
what are the secondary risks for thrombophilia?
|
prolonged rest
MI AF tissue injury cancer prosthetic valves DIC HITTS APLAS |
|
what causes HITS?
|
after unfractionated heparin, antibodies recognising heparin/platelet factor 4 complexes on surface of platelets as well as these complexes on endothelial cells -> activation, aggreation & consumption of platelets -> platelet activation & endothelial damage -> prothrombotic state (despite heparin & low platelet counts)
|
|
what is thought to be the prothrombotic mechanism in APLAS?
|
antibody binds to binding sites on plasma proteins like prothrombin which are unveiled by phospholipids -> mlti effect where endothelium is injured + platelets & complement activated
|
|
what is secondary APLAS?
|
APLAS if they already have an autoimmune disease eg lupus
|
|
where do thrombi develop?
|
anywhere in the cardiovascular system - usually at sites of turbulence in cardiac/arterial & sites of stasis in venous
|
|
where do thrombi extend?
|
towards the heart - arterial thrombi tend to grow retrograde whereas venous thrombi grow in direction of flow
|
|
what are mural thrombi?
|
thrombi in heart chambers or aortic lumen
|
|
what are the most common sites of occlusive arterial thrombi
|
in order:
coronary, cerebral & femoral |
|
what four events occur to a thrombus after it has formed?
|
propagation
embolisation dissoution organization/recanalization |
|
what is propagation of thrombi?
|
accumulation of additional platelets & fibrin
|
|
what is embolisation?
|
dislodging of thrombus which then travels to other sites
|
|
what is dissolution of thrombus?
|
result of fibrinolysis (older thrombi are more resistant as have extensive fibrin deposition & crosslinking - why tPA is only effective in first few hours)
|
|
what happens when a thrombus is organised?
|
ingrowth of endothelium, smooth muscle & fibrobasts with capillary channels re-establishing continuity of original lumen
|
|
what is the fate of a thrombus that is continuously recanalized?
|
may turn into connective tissue which is incorporated into vessel wall
|
|
where are most superficial venous thrombi in the leg?
|
saphenous veins in the setting of varicosities
|
|
what is the embolisation risk of superficial leg thrombi? what are the other risks?
|
low risk of embolus
predispose to overlying varicose ulcers |
|
in what percentage of individuals are DVTs asymptomatic & why
|
50% because venous obstructions can be offset by collateral channels
|
|
what factors in trauma/surgery/burns lead to hypercoagulability?
|
immobilisation
plus vascular insult procoagulant release from injured tissue increased hepatic synthesis of coag factors altered tPA production |
|
what is migratory thrombophlebitis/Trousseau syndrome?
|
increased risk of thromboembolism in disseminated cancers: inflamm & coag factors (tissue factor & factor VIII) released from tumour cells
|
|
what is a major cause of arterial thrombosis?
|
atherosclerosis
|
|
what is DIC?
|
sudden or insiious onset of widespread fibrin thrombi in the microcirculation
|
|
why is DIC aka consumption coagulopathy?
|
platelets & coag proteins are consumed
|
|
is DIC a primary disease?
|
no, it's a potential complication of any condition associated with widespread activation of thrombin
|
|
what is an embolus?
|
detached intravascular solid, liquid or gaseous mass carried by the blood to a site distant from its point of origin
|
|
what percentage of PEs originate from DVTs? how much more common are DVTs than PEs?
|
95% PEs have DVT origin
but DVTs occur 2-3x more commonly than PEs |
|
what is paradoxical embolism?
|
an embolus passes through an interatrial/interventricular defect & gains access to systemic circulation
|
|
what percentage of PEs are clinically silent & why?
|
60-80%
because they are small |
|
in what kind of pulmonary vascular does PE usually cause haemorrhage or infarct?
|
small end arteriolar pulmonary branches
|
|
what is the possible end point of multiple emboli over time? (2)
|
pulmonary HT
R ventricular failure |
|
in what kind of pulmonary vascular does PE usually cause haemorrhage or infarct?
|
small end arteriolar pulmonary branches
|
|
what is the possible end point of multiple emboli over time? (2)
|
pulmonary HT
R ventricular failure |
|
what percentage of arterial emboli come from the heart?
|
80% from intracardiac mural thrombi
|
|
what conditions are intracardiac mural thrombi associated with?
|
2/3 w L ventricular wall infarcts
1/4 w L atrial dilatation & fibrillation the rest from aortic aneurysms, thrombi on ulcerated atherosclerosis or valvular vegetation |
|
what percentage of systemic emboli are of unknown origin?
|
10-15%
|
|
what are the two major sites of arteriolar embolisation?
|
lower extremities 75%
brain 10% |
|
what percentage of those w severe skeletal injuries have fat embolism? what percentage of those have clinical finding?
|
90%
but 10% have findings |
|
what characterises fat embolism (4)
|
pulmonary insufficiency
neurological symptoms anaemia thrombocytopaenia |
|
what is the typical onset of fat embolism?
|
sudden onset 1-3 days post injury of tachypnoea, dyspnoea, tachycardia
irritability/restlessness -> delirium/coma |
|
where does the thrombocytopaenia in fat embolism come from?
|
platelet adhesion to fat globules & subsequent aggregation/splenic sequestration
|
|
where does the anaemia in fat embolism come from?
|
similar to thrombocytopaenia - red cell aggregation/haemolysis
|
|
what effect do free fatty acids released from fat globules have on endothelium?
|
toxic
|
|
what volume of air is required to have occlusive effect in the pulmonary circulation? what cardiac/neuro?
|
about 100cc of air for pulmonary affect
only need a very small volume trapped in cardiac/neurosurgery for effect |
|
what is decompression sickness?
|
gas embolism occuring when there is a sudden decrease in atmospheric pressure -> nitrogen comes out of solution in blood/tissues
|
|
what are the complications of chronic gas embolism?
|
persistent gas emboli in skeletal system -> multiple ischaemic foci esp at femoral heads, tibia & humeri
|
|
what is the bends?
|
rapid formation of gas bubbles in skeletal muscle & joint tissues
|
|
what is the chokes
|
gas bubbles in the pulmonary vasculature -> oedema, haemorrhage, focal atelectasis or emphysema
|
|
how common is amniotic fluid embolism?
|
rare - 1 in 40000
|
|
what is the mortality of amniotic fluid embolism?
|
80%
|
|
what happens if the patient survives the initial amniotic fluid embolism crisis?
|
pulmonary oedema
plus DIC in 50% (amniotic fluid is thrombogenic) |
|
what is an infarct?
|
an area of ischaemic necrosis caused by occlusion of arterial supply or venous drainage
|
|
what conditions are required for venous thrombosis to cause infarct?
|
in organs with a single efferent vein eg testis/ovary
|
|
how do we classify infarcts?
|
red (haemorrhagic) vx white (anaemic)
septic vs bland (infection vs none) |
|
when do white infarcts occur?
|
with end arterial occlusion where adjacent capillary beds can't seep into adjoining area
|
|
when do red infarcts occur?
|
in venous or dual circulations or loose tissues (eg lung) where blood can collect into infarcted zone
|
|
when are the margins of infarcts well defined?
|
after enough time has passed to allow a narrow ring of inflammation to form
|
|
when are haemorrhagic infarcts the rule?
|
in the lung
|
|
what is the dominant histologic characteristic of infarction?
|
ischaemic coagulative necrosis
|
|
what ultimately replaces most infarcts? what is the exception
|
a scar
except in brain -> liquefactive necrosis |
|
what determines the eventual outcome of infarcts? (4)
|
1. nature of vascular supply
2. rate at which occlusion develops 3. vulnerability to hypoxia 4. oxygen content of blood |
|
after what time do neurons undergo irreversible damage when deprived of their blood supply?
|
4 min
|
|
how long do myocardium have to survive total ischaemia?
|
20-30 min
|
|
what is the definition of oedema?
|
abnormal increase in interstitial fluid
|